EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High Diagnostic Yield of Testing With a Diabetes Device Screening Series in Patients With Suspected Allergic Reactions to Glucose Sensors, Insulin Patch Pumps and Insulin Infusion Sets

Norbertus A Ipenburg iD, Emma M van Oers, Anton C de Groot iD, Mounir Yaâkoubi, Thomas Rustemeyer iD

Contact Dermatitis · 02.11.2026

DOI: 10.1111/cod.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, online erschienen am 02.11.2026. Verfasst von Norbertus A Ipenburg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Center, Amsterdam, the Netherlands. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patch testing in patients with dermatitis from diabetes devices is challenging because device composition is nearly always undisclosed, relevant allergens are incompletely known, and many suspected allergens are not commercially available.

Objectives

To evaluate the diagnostic yield of a dedicated diabetes device screening series, supplemented with a (meth)acrylate series and testing of patients' own device adhesives and adhesive extracts, in patients with suspected allergic contact dermatitis to glucose sensors, insulin patch pumps, or infusion sets. Materials and Methods We performed a retrospective patch test study of 100 patients referred to a tertiary referral centre for suspected allergic reactions to diabetes devices.

Results

Seventy‐one patients reacted to one or more allergens in the diabetes device screening series; in 50 (70.4%), at least one reaction was clinically relevant. The most frequent relevant allergens were colophonium and its related substances abietic acid and hydroabietyl alcohol, isobornyl acrylate, dicyclohexylmethane‐4,4′‐diisocyanate, and N,N ‐dimethylacrylamide. The (meth)acrylate series had no clear additional diagnostic value. Testing with patients' own device adhesives and extracts frequently identified allergic reactions to devices not recognised by the results of the screening series alone.

Conclusion

The combined approach identified relevant contact allergies in most patients with suspected allergic contact dermatitis to diabetes devices.

Schlagwörter

Stichwörter der Autor:innen

adhesive extractallergic contact dermatitiscolophoniumdiabetesdicyclohexylmethane‐4,4′‐diisocyanateglucose sensorinsulin pumpisobornyl acrylatepatch testingscreening series

Autor:innen und Institutionen

  • Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Amsterdam University Medical Centers, Amsterdam, the Netherlands.

ORCID-Profile: Norbertus A Ipenburg, Anton C de Groot, Thomas Rustemeyer

Zitieren

APA

Ipenburg, N. A., van Oers, E. M., de Groot, A. C., Yaâkoubi, M., & Rustemeyer, T. (2026). High Diagnostic Yield of Testing With a Diabetes Device Screening Series in Patients With Suspected Allergic Reactions to Glucose Sensors, Insulin Patch Pumps and Insulin Infusion Sets. Contact Dermatitis. https://doi.org/10.1111/cod.70275

Vancouver

Ipenburg NA, van Oers EM, de Groot AC, Yaâkoubi M, Rustemeyer T. High Diagnostic Yield of Testing With a Diabetes Device Screening Series in Patients With Suspected Allergic Reactions to Glucose Sensors, Insulin Patch Pumps and Insulin Infusion Sets. Contact Dermatitis. 2026. doi:10.1111/cod.70275

BibTeX
@article{Ipenburg2026,
  author = {Ipenburg, Norbertus A and van Oers, Emma M and de Groot, Anton C and Yaâkoubi, Mounir and Rustemeyer, Thomas},
  title = {High Diagnostic Yield of Testing With a Diabetes Device Screening Series in Patients With Suspected Allergic Reactions to Glucose Sensors, Insulin Patch Pumps and Insulin Infusion Sets},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70275}
}
Kostenlos starten →